Integral Derivatives’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.79M Buy
13,981
+3,399
+32% +$459K 0.04% 132
2017
Q4
$1.48M Buy
10,582
+3,730
+54% +$520K 0.03% 374
2017
Q3
$891K Buy
+6,852
New +$908K 0.02% 533
2017
Q2
Sell
-15,953
Closed -$2.04M 1183
2017
Q1
$1.99M Buy
+15,953
New +$1.91M 0.04% 313
2016
Q4
Sell
-26,280
Closed -$3.04M 1205
2016
Q3
$3.1M Buy
+26,280
New +$3.19M 0.06% 181
2015
Q2
Sell
-31,289
Closed -$3.13M 1183
2015
Q1
$3.15M Buy
31,289
+11,740
+60% +$1.19M 0.07% 180
2014
Q4
$2.04M Buy
19,549
+12,745
+187% +$1.34M 0.04% 432
2014
Q3
$725K Buy
+6,804
New +$706K 0.01% 836

Other funds holding JNJ

Integral Derivatives's JNJ Position: Q1 2018 in Review

Integral Derivatives increased its Johnson & Johnson (JNJ) stake by 32% in Q1 2018, buying an estimated $459K and bringing the position to 13,981 shares worth $1.79M. The position accounts for 0.04% of the portfolio, ranked #132.

Integral Derivatives first reported a position in JNJ in Q3 2014 and has held it in 8 quarters since. The position peaked at $3.15M in Q1 2015. 2,598 funds tracked by Wall St. Rank hold JNJ as of Q1 2018.

  • Integral Derivatives held 13,981 shares of Johnson & Johnson worth $1.79M as of Q1 2018.
  • Integral Derivatives bought 3,399 Johnson & Johnson shares in Q1 2018, an estimated $459K.
  • Johnson & Johnson made up 0.04% of Integral Derivatives's portfolio in Q1 2018, its #132 holding.
  • Integral Derivatives first reported a position in Johnson & Johnson in Q3 2014 and has held it in 8 quarters since.
  • Integral Derivatives's Johnson & Johnson position peaked at $3.15M in Q1 2015.
  • 2,598 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.